Skip to content
10-Q

Quarterly Report

Verrica Pharmaceuticals Inc. VRCA

0000950170-25-107358

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 9.45M sh
Shares Diluted Q2 2025 · Jun 30, 2025 9.49M sh
Shares Diluted Q2 2025 · Jun 30, 2025 9.49M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 4.65M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 4.65M sh
Capex Q2 2025 · Jun 30, 2025 $0
Capex Q2 2025 · Jun 30, 2024 $11K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$22.72M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$36.31M
Long Term Debt Q2 2025 · Jun 30, 2025 $24.58M
Long Term Debt Q2 2025 · Dec 31, 2024 $30.98M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $15.4M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $46.33M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$17.48M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$18.58M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$9.86M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$13.3M
Stockholders Equity Q2 2025 · Mar 31, 2024 $1.51M
Stockholders Equity Q2 2025 · Dec 31, 2023 $19.76M
Current Liabilities Q2 2025 · Jun 30, 2025 $29.22M
Current Liabilities Q2 2025 · Dec 31, 2024 $29.01M
Total Liabilities Q2 2025 · Jun 30, 2025 $56.59M
Total Liabilities Q2 2025 · Dec 31, 2024 $63.99M
Current Assets Q2 2025 · Jun 30, 2025 $36.78M
Current Assets Q2 2025 · Dec 31, 2024 $51.18M
Total Assets Q2 2025 · Jun 30, 2025 $39.11M
Total Assets Q2 2025 · Dec 31, 2024 $54.13M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.02
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.01
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$3.70
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$8.07
Eps Basic Q2 2025 · Jun 30, 2025 $0.02
Eps Basic Q2 2025 · Jun 30, 2025 −$1.01
Eps Basic restated Q2 2025 · Jun 30, 2024 −$3.70
Eps Basic restated Q2 2025 · Jun 30, 2024 −$8.07
Sga Expense Q2 2025 · Jun 30, 2025 $8.85M
Sga Expense Q2 2025 · Jun 30, 2025 $17.7M
Sga Expense Q2 2025 · Jun 30, 2024 $16.52M
Sga Expense Q2 2025 · Jun 30, 2024 $32.86M
Rd Expense Q2 2025 · Jun 30, 2025 $1.85M
Rd Expense Q2 2025 · Jun 30, 2025 $4.13M
Rd Expense Q2 2025 · Jun 30, 2024 $3.32M
Rd Expense Q2 2025 · Jun 30, 2024 $8.27M
Net Income Q2 2025 · Jun 30, 2025 $204K
Net Income Q2 2025 · Jun 30, 2025 −$9.54M
Net Income Q2 2025 · Mar 31, 2025 −$9.74M
Net Income Q2 2025 · Jun 30, 2024 −$17.19M
Net Income Q2 2025 · Jun 30, 2024 −$37.52M
Net Income Q2 2025 · Mar 31, 2024 −$20.33M
Operating Income Q2 2025 · Jun 30, 2025 $1.51M
Operating Income Q2 2025 · Jun 30, 2025 −$6.62M
Operating Income Q2 2025 · Jun 30, 2024 −$15.21M
Operating Income Q2 2025 · Jun 30, 2024 −$33.81M
Revenue Q2 2025 · Jun 30, 2025 $12.7M
Revenue Q2 2025 · Jun 30, 2025 $16.14M
Revenue Q2 2025 · Jun 30, 2024 $5.18M
Revenue Q2 2025 · Jun 30, 2024 $9M